• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结清扫数量及一种新的风险分层对老年局部晚期食管腺癌预后的影响

Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma.

作者信息

Wu Yahua, Gu Weiwei, Du Bin, Lv Chengliu, Yao Na, Zhu Yingjiao, Ouyang Jingxiang, Lai Jinhuo

机构信息

Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, 350000, Fujian, China.

Department of Medical Oncology, People's Hospital Affiliated to Shandong First Medical University, Jinan, 271100, Shandong, China.

出版信息

J Cancer. 2024 Jun 3;15(13):4197-4204. doi: 10.7150/jca.96574. eCollection 2024.

DOI:10.7150/jca.96574
PMID:38947388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11212079/
Abstract

Elderly patients with locally advanced esophageal adenocarcinoma (EAC) have a poor prognosis. The purpose of this study was to identify prognostic factors and construct a risk stratification for assessing the prognosis of elderly (≥ 70 years old) EAC patients who receiving neoadjuvant chemoradiotherapy (NCRT) and esophagectomy. A total of 688 patients with non-metastatic locally advanced EAC who underwent NCRT and esophagectomy were selected from the Surveillance Epidemiology and End Results (SEER) database. Multivariable Cox analysis was used to identify prognostic factors of overall survival (OS). Restricted Cubic Splines (RCS) was used to examine the linear relationship between the number of lymph node dissection (LND) and OS. RCS showed a linear relationship between LND and OS (P = 0.690). As the number of LND increased, the risk of death decreased. Multivariable analysis demonstrated that LND > 23, grade III/IV, and regional node positive were independent prognostic factors. Subgroup analysis indicated that enlarged lymph node dissection (LND > 23) did not improve OS in patients with grade I/II or T1-2 stage, whereas enlarged lymph node dissection significantly improved OS in patients with grade III/IV or T3-4 stage. Furthermore, we constructed a novel risk score based on LND, grade, and regional node status, which stratified patients into low-, medium-, and high-risk groups. Patients in the high-risk group (risk score = 3) had a worse prognosis. Enlarged lymph node dissection (LND > 23) improved OS in patients with grade III/IV or T3-4 stage. Moreover, a novel risk score was constructed, which facilitated risk stratification and postoperative surveillance in elderly EAC patients.

摘要

局部晚期食管腺癌(EAC)老年患者预后较差。本研究旨在确定预后因素,并构建风险分层系统,以评估接受新辅助放化疗(NCRT)和食管切除术的老年(≥70岁)EAC患者的预后。从监测、流行病学和最终结果(SEER)数据库中选取了688例接受NCRT和食管切除术的非转移性局部晚期EAC患者。采用多变量Cox分析确定总生存期(OS)的预后因素。使用限制立方样条(RCS)检验淋巴结清扫数量(LND)与OS之间的线性关系。RCS显示LND与OS之间存在线性关系(P = 0.690)。随着LND数量增加,死亡风险降低。多变量分析表明,LND>23、III/IV级和区域淋巴结阳性是独立的预后因素。亚组分析表明,对于I/II级或T1-2期患者,扩大淋巴结清扫(LND>23)并未改善OS,而对于III/IV级或T3-4期患者,扩大淋巴结清扫显著改善了OS。此外,我们基于LND、分级和区域淋巴结状态构建了一个新的风险评分系统,将患者分为低、中、高风险组。高风险组(风险评分为3)患者预后较差。扩大淋巴结清扫(LND>23)改善了III/IV级或T3-4期患者的OS。此外,构建了一个新的风险评分系统,有助于老年EAC患者的风险分层和术后监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/41b301cafe8b/jcav15p4197g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/851866fc2881/jcav15p4197g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/b3f296b19666/jcav15p4197g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/36b3f31782ae/jcav15p4197g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/41b301cafe8b/jcav15p4197g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/851866fc2881/jcav15p4197g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/b3f296b19666/jcav15p4197g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/36b3f31782ae/jcav15p4197g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5b/11212079/41b301cafe8b/jcav15p4197g004.jpg

相似文献

1
Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma.淋巴结清扫数量及一种新的风险分层对老年局部晚期食管腺癌预后的影响
J Cancer. 2024 Jun 3;15(13):4197-4204. doi: 10.7150/jca.96574. eCollection 2024.
2
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.肝内胆管癌准确的淋巴结分期需要充分的淋巴结清扫: 一项基于人群的研究。
Cancer Med. 2023 Apr;12(7):8184-8198. doi: 10.1002/cam4.5620. Epub 2023 Jan 16.
3
Prognostic significance of the number of lymph nodes dissection in esophageal adenocarcinoma patients.食管腺癌患者淋巴结清扫数量的预后意义
Transl Cancer Res. 2020 May;9(5):3406-3415. doi: 10.21037/tcr-19-2802.
4
The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non-Small Cell Lung Cancer: A Population-Based Study.淋巴结清扫对IV期非小细胞肺癌原发肿瘤切除的预后影响:一项基于人群的研究。
Front Oncol. 2022 May 5;12:853257. doi: 10.3389/fonc.2022.853257. eCollection 2022.
5
Lymph Nodes Dissection in Elderly Patients with T3-T4 Laryngeal Cancer.老年 T3-T4 声门型喉癌患者行淋巴结清扫术。
Clin Interv Aging. 2020 Dec 8;15:2321-2330. doi: 10.2147/CIA.S283600. eCollection 2020.
6
Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database.无远处转移胃癌淋巴结密度在癌症分期系统中的预后价值:基于 SEER 数据库的人群分析。
World J Surg Oncol. 2022 Sep 29;20(1):325. doi: 10.1186/s12957-022-02795-9.
7
Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.新辅助放化疗后局部晚期直肠癌淋巴结转移分布的预后价值
Front Surg. 2021 Nov 17;8:749575. doi: 10.3389/fsurg.2021.749575. eCollection 2021.
8
Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.增加切除的淋巴结站数可提高食管鳞状细胞癌的生存率。
BMC Cancer. 2024 Feb 5;24(1):177. doi: 10.1186/s12885-024-11886-7.
9
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.淋巴结清扫对局部晚期食管鳞状细胞癌新辅助放化疗后生存的影响:来自多中心随机研究NEOCRTEC5010的结果
Ann Surg. 2023 Feb 1;277(2):259-266. doi: 10.1097/SLA.0000000000004798. Epub 2023 Jan 10.
10
Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review.影响 Wilms 瘤患者淋巴结采样模式的因素及淋巴结密度对生存的影响:监测、流行病学和最终结果(SEER)数据库回顾。
J Pediatr Urol. 2020 Feb;16(1):81-88. doi: 10.1016/j.jpurol.2019.10.030. Epub 2019 Nov 6.

引用本文的文献

1
Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma.基于列线图的风险分层分析新辅助免疫化疗后局部晚期食管鳞癌患者接受术后辅助治疗的价值。
Front Immunol. 2025 Jul 28;16:1621607. doi: 10.3389/fimmu.2025.1621607. eCollection 2025.
2
Lymph node metastases status in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: a single-center cross-sectional study.新辅助放化疗后食管鳞状细胞癌的淋巴结转移状态:一项单中心横断面研究
Transl Gastroenterol Hepatol. 2025 Jan 17;10:8. doi: 10.21037/tgh-24-76. eCollection 2025.

本文引用的文献

1
Esophageal cancer in China: Practice and research in the new era.中国食管癌:新时代的实践与研究。
Int J Cancer. 2023 May 1;152(9):1741-1751. doi: 10.1002/ijc.34301. Epub 2022 Oct 5.
2
An Editorial on Lymphadenectomy in Esophagectomy for Cancer.一篇关于食管癌切除术淋巴结清扫的社论。
Ann Surg Oncol. 2022 Aug;29(8):4676-4678. doi: 10.1245/s10434-022-11736-5. Epub 2022 Apr 30.
3
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.新辅助放化疗联合手术治疗食管癌的 10 年结果:随机对照 CROSS 试验。
J Clin Oncol. 2021 Jun 20;39(18):1995-2004. doi: 10.1200/JCO.20.03614. Epub 2021 Apr 23.
4
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.纳武利尤单抗辅助治疗食管或胃食管结合部癌。
N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Examined lymph node count is not associated with prognosis in elderly patients with pN0 thoracic esophageal cancer.检查的淋巴结计数与 pN0 胸段食管癌老年患者的预后无关。
Medicine (Baltimore). 2021 Jan 15;100(2):e24100. doi: 10.1097/MD.0000000000024100.
7
Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better?新辅助放化疗后行淋巴结清扫术对食管腺癌患者的生存影响:清扫越多越好吗?
J Gastrointest Surg. 2020 Nov;24(11):2447-2455. doi: 10.1007/s11605-020-04750-z. Epub 2020 Sep 1.
8
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗(FLOT4):一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
9
Age-Related Decline in Primary CD8 T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8 T Cells.与虚拟记忆 CD8 T 细胞衰老相关的原发性 CD8 T 细胞反应的年龄相关性下降。
Cell Rep. 2018 Jun 19;23(12):3512-3524. doi: 10.1016/j.celrep.2018.05.057.
10
Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.新辅助放化疗可改善老年食管癌患者的总生存。
J Geriatr Oncol. 2018 Jan;9(1):40-46. doi: 10.1016/j.jgo.2017.08.010. Epub 2017 Sep 6.